NCT00862667View on ClinicalTrials.gov

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

Treatment A

PF-00241939 300ug using Inhaler A

DRUG

Treatment B

PF-00241939 300ug using Inhaler B

DRUG

Treatment C

PF-00241939 300ug using Inhaler C

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY